It's the peptide-mhc affinity, stupid

Cancer Cell

Volumn 23, Issue 4, 2013, Pages 429-431

  Kammertoens, Thomas ^a,b   Blankenstein, Thomas ^a,b  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN GP 100; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR;

CD8+ T LYMPHOCYTE; CELL FUNCTION; HUMAN; IC 50; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE; TUMOR RECURRENCE; TUMOR REGRESSION;

EID: 84876356880     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2013.04.004     Document Type: Short Survey

References (10)

1. Anders K., Blankenstein T. Clin. Cancer Res. 2013, 19:320-326.
2. Blankenstein T., Coulie P.G., Gilboa E., Jaffee E.M. Nat. Rev. Cancer 2012, 12:307-313.
3. Bos R., van Duikeren S., Morreau H., Franken K., Schumacher T.N., Haanen J.B., van der Burg S.H., Melief C.J., Offringa R. Cancer Res. 2008, 68:8446-8455.
4. Engels B., Chervin A.S., Sant A.J., Kranz D.M., Schreiber H. Mol. Ther. 2012, 20:652-660.
5. Engels B., Engelhard V.H., Sidney J., Sette A., Binder D.C., Liu R.B., Kranz D.M., Meredith S.C., Rowley D.A., Schreiber H. Cancer Cell 2013, 23:516-526. this issue.
6. Johnson L.A., Morgan R.A., Dudley M.E., Cassard L., Yang J.C., Hughes M.S., Kammula U.S., Royal R.E., Sherry R.M., Wunderlich J.R., et al. Blood 2009, 114:535-546.
7. Schreiber H. Cancer Immunology. Fundamental Immunology 2013, 1200-1234. Lippincott Williams and Wilkins, a Wolters Kluwer business, Philadelphia, PA, USA. Seventh Edition. W.E. Paul (Ed.).
8. Schreiber H., Rowley D.A. Science 2008, 319:164-165.
9. Schumacher T.N. Nat. Rev. Immunol. 2002, 2:512-519.
10. Stone J.D., Chervin A.S., Kranz D.M. Immunology 2009, 126:165-176.